A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 1,993 shares of MDGL stock, worth $631,960. This represents 0.83% of its overall portfolio holdings.

Number of Shares
1,993
Previous 1,333 49.51%
Holding current value
$631,960
Previous $373,000 13.14%
% of portfolio
0.83%
Previous 0.63%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$212.22 - $292.96 $140,065 - $193,353
660 Added 49.51%
1,993 $422,000
Q1 2024

May 08, 2024

BUY
$171.37 - $283.23 $4,798 - $7,930
28 Added 2.15%
1,333 $355,000
Q4 2023

Jan 19, 2024

BUY
$120.4 - $237.13 $157,122 - $309,454
1,305 New
1,305 $301,000
Q2 2019

Jul 19, 2019

SELL
$91.13 - $142.5 $150,455 - $235,267
-1,651 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$103.48 - $143.84 $170,845 - $237,479
1,651 New
1,651 $207,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.42B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.